GPR17 and Peripheral demyelination: Globally, these data suggest that, at variance from EAE, in this model of demyelination, GPR17+ OPCs are able to react to the toxic damage induced by cuprizone administration by first expanding their pool and then progressing to terminally differentiated cells, thus effectively participating to remyelination.